Literature DB >> 16539676

The norepinephrine transporter and its regulation.

Prashant Mandela1, Gregory A Ordway.   

Abstract

For many years, the norepinephrine transporter (NET) was considered a 'static' protein that contributed to the termination of the action of norepinephrine in the synapse of noradrenergic neurons. The concept that the NET is dynamically regulated, adjusting noradrenergic transmission by changing its function and/or expression, was considered initially in the mid 1980s. Since that time, a plethora of studies demonstrate that the NET is regulated by several intracellular and extracellular signaling molecules, and that phosphorylation of the NET is a major pathway regulating its cell surface expression and thereby its function. The NET is a target of action of a number of drugs that are used long-term therapeutically or abused chronically. This has driven numerous investigations of how the NET and its function are regulated by long-term exposure to drugs. While repeated exposure to many drugs has been shown to affect NET function and expression, the intracellular mechanisms for these effects remains elusive.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16539676     DOI: 10.1111/j.1471-4159.2006.03717.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

1.  Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.

Authors:  Heinrich J G Matthies; Jessica L Moore; Christine Saunders; Dawn Signor Matthies; Lynne A Lapierre; James R Goldenring; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.

Authors:  Prashant Mandela; Michelle Chandley; Yao-Yu Xu; Meng-Yang Zhu; Gregory A Ordway
Journal:  Neurochem Int       Date:  2010-02-20       Impact factor: 3.921

3.  Evaluation of specific neural marker GAP-43 and TH combined with Masson-trichrome staining for forensic autopsy cases with old myocardial infarction.

Authors:  Tian-Shui Yu; Xu Wang; Hai-Dong Zhang; Ru-Feng Bai; Rui Zhao; Da-Wei Guan
Journal:  Int J Legal Med       Date:  2017-04-11       Impact factor: 2.686

Review 4.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

5.  Upregulation of norepinephrine transporter function by prolonged exposure to nicotine in cultured bovine adrenal medullary cells.

Authors:  Hideaki Itoh; Yumiko Toyohira; Susumu Ueno; Satoru Saeki; Han Zhang; Yumi Furuno; Kojiro Takahashi; Masato Tsutsui; Kenji Hachisuka; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-31       Impact factor: 3.000

6.  Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine β-hydroxylase in adult rat brains.

Authors:  Y Fan; J Huang; M Duffourc; R L Kao; G A Ordway; R Huang; M-Y Zhu
Journal:  Neuroscience       Date:  2011-07-16       Impact factor: 3.590

Review 7.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

8.  Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function.

Authors:  Yejun Zhao; Lena Sun
Journal:  J Clin Neurosci       Date:  2008-09-23       Impact factor: 1.961

9.  Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro.

Authors:  Maria A Nikolaeva; Sandra Richard; Abdeslam Mouihate; Peter K Stys
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

10.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.